209 related articles for article (PubMed ID: 18436083)
1. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans.
Lea J; Cheek D; Thornley-Brown D; Appel L; Agodoa L; Contreras G; Gassman J; Lash J; Miller ER; Randall O; Wang X; McClellan W;
Am J Kidney Dis; 2008 May; 51(5):732-40. PubMed ID: 18436083
[TBL] [Abstract][Full Text] [Related]
2. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study.
Olivo RE; Davenport CA; Diamantidis CJ; Bhavsar NA; Tyson CC; Hall R; Bidulescu A; Young B; Mwasongwe SE; Pendergast J; Boulware LE; Scialla JJ
Nephrol Dial Transplant; 2018 Jun; 33(6):992-1001. PubMed ID: 28992354
[TBL] [Abstract][Full Text] [Related]
3.
Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
[TBL] [Abstract][Full Text] [Related]
4. Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.
Erickson KF; Lea J; McClellan WM
Clin J Am Soc Nephrol; 2013 Jan; 8(1):75-81. PubMed ID: 23085727
[TBL] [Abstract][Full Text] [Related]
5. Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
Duru OK; Li S; Jurkovitz C; Bakris G; Brown W; Chen SC; Collins A; Klag M; McCullough PA; McGill J; Narva A; Pergola P; Singh A; Norris K
Am J Kidney Dis; 2008 Feb; 51(2):192-8. PubMed ID: 18215697
[TBL] [Abstract][Full Text] [Related]
6. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
[TBL] [Abstract][Full Text] [Related]
7. Cardiorenal metabolic syndrome in the African diaspora: rationale for including chronic kidney disease in the metabolic syndrome definition.
Lea JP; Greene EL; Nicholas SB; Agodoa L; Norris KC
Ethn Dis; 2009; 19(2 Suppl 2):S2-11-14. PubMed ID: 19537345
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study.
DeBoer MD; Filipp SL; Musani SK; Sims M; Okusa MD; Gurka M
Kidney Blood Press Res; 2018; 43(2):555-567. PubMed ID: 29642060
[TBL] [Abstract][Full Text] [Related]
9. Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients.
Dai H; Lu S; Tang X; Lu M; Chen R; Chen Z; Yang P; Liu C; Zhou H; Lu Y; Yuan H
Kidney Blood Press Res; 2016; 41(4):413-23. PubMed ID: 27355680
[TBL] [Abstract][Full Text] [Related]
10. Intensive blood-pressure control in hypertensive chronic kidney disease.
Appel LJ; Wright JT; Greene T; Agodoa LY; Astor BC; Bakris GL; Cleveland WH; Charleston J; Contreras G; Faulkner ML; Gabbai FB; Gassman JJ; Hebert LA; Jamerson KA; Kopple JD; Kusek JW; Lash JP; Lea JP; Lewis JB; Lipkowitz MS; Massry SG; Miller ER; Norris K; Phillips RA; Pogue VA; Randall OS; Rostand SG; Smogorzewski MJ; Toto RD; Wang X;
N Engl J Med; 2010 Sep; 363(10):918-29. PubMed ID: 20818902
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and awareness of CKD among African Americans: the Jackson Heart Study.
Flessner MF; Wyatt SB; Akylbekova EL; Coady S; Fulop T; Lee F; Taylor HA; Crook E
Am J Kidney Dis; 2009 Feb; 53(2):238-47. PubMed ID: 19166799
[TBL] [Abstract][Full Text] [Related]
12.
Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
[TBL] [Abstract][Full Text] [Related]
13. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; So WY; Ma RC; Kong AP; Ozaki R; Ng VS; Yu LW; Lau WW; Yang X; Chow FC; Chan JC; Tong PC;
Diabetes Care; 2008 Dec; 31(12):2357-61. PubMed ID: 18835954
[TBL] [Abstract][Full Text] [Related]
15. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Lea J; Greene T; Hebert L; Lipkowitz M; Massry S; Middleton J; Rostand SG; Miller E; Smith W; Bakris GL
Arch Intern Med; 2005 Apr; 165(8):947-53. PubMed ID: 15851648
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.
Appel LJ; Wright JT; Greene T; Kusek JW; Lewis JB; Wang X; Lipkowitz MS; Norris KC; Bakris GL; Rahman M; Contreras G; Rostand SG; Kopple JD; Gabbai FB; Schulman GI; Gassman JJ; Charleston J; Agodoa LY;
Arch Intern Med; 2008 Apr; 168(8):832-9. PubMed ID: 18443258
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).
Chen TK; Estrella MM; Astor BC; Greene T; Wang X; Grams ME; Appel LJ
Nephrol Dial Transplant; 2015 Aug; 30(8):1329-35. PubMed ID: 25817226
[TBL] [Abstract][Full Text] [Related]
18. Correlates of N-terminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American Study of Kidney Disease and Hypertension.
Yi S; Contreras G; Miller ER; Appel LJ; Astor BC
Am J Nephrol; 2009; 29(4):292-8. PubMed ID: 18824845
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and outcomes in African Americans with CKD.
Porter A; Fischer MJ; Wang X; Brooks D; Bruce M; Charleston J; Cleveland WH; Dowie D; Faulkner M; Gassman J; Hiremath L; Kendrick C; Kusek JW; Norris KC; Thornley-Brown D; Greene T; Lash JP;
J Am Soc Nephrol; 2014 Aug; 25(8):1849-55. PubMed ID: 24700865
[TBL] [Abstract][Full Text] [Related]
20. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
